Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Mar 2023
Avascular necrosis (AVN) is considered an iatrogenic complication after treatment for progressive hip dysplasia, but research in China has revealed two characteristics associated with this condition. ossification nuclei.
Read Full NewsThe history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.
US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.
Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.
Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.
A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.
Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.
1.
GuCS: Genitourinary Cancers Symposium
2.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
3.
Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors
4.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
5.
FDA Approves Subcutaneous Isatuximab for MM Indications
1.
Comprehensive Updates in Hematology and Quality Improvement
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
Diagnostic Evaluation of Iron Deficiency Anemia in Adults
4.
A New Perspective on Spherocytosis: Uncovering Innovative Treatments
5.
Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
2.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
3.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
4.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
5.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge